[Market Focus] BioBijou Surges 180% on First Day of KOSDAQ Listing

BioBijou is showing an increase of over 180% compared to its IPO price on its first day of listing on KOSDAQ.

The KOSDAQ Market Division of the Korea Exchange held a listing ceremony for BioBijou, a company engaged in the manufacturing, sales, and distribution of skin boosters, fillers, and other products, on the 20th at the Seoul office publicity center. Korea Exchange

As of 9:08 a.m. on May 20, at the Korea Exchange, BioBijou was trading at 25,650 won, up 16,550 won (181.87%) from its IPO price of 9,100 won.

Previously, BioBijou had set its final IPO price at the upper end of the price band, 9,100 won, through a book-building process conducted from April 23 to 29 for domestic and overseas institutional investors. A total of 2,466 institutions participated, resulting in a competition ratio of 1,094.25 to 1. In the subsequent public subscription for general investors held on May 8 and 9, the competition ratio was 1,133.52 to 1, and a total of 4.0229 trillion won was collected as subscription deposits.

Founded in 2018, BioBijou is a company that independently develops, manufactures, and sells a variety of medical aesthetic products such as skin boosters and HA fillers. The company has established a business model that allows it to manage the entire process of development, production, and sales in-house, and has secured differentiated competitiveness in each value chain. Its main brands include KANDOLUV, ACENART, and CORENA.

This content was produced with the assistance of AI translation services.